JT
NGNE icon

Jump Trading’s Neurogene NGNE Stock Holding History

Jump Trading’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-915
Closed -$54K – 354
2018
Q3 		$54K Buy
+915
New +$54K ﹤0.01% 418

Other funds holding NGNE

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

Jump Trading's NGNE Position: Q4 2018 in Review

Jump Trading sold out of Neurogene (NGNE) in Q4 2018, closing a stake of 915 shares — an estimated $54K sold.

Jump Trading first reported a position in NGNE in Q3 2018 and held it in 1 quarter. The position peaked at $54K in Q3 2018. 36 funds tracked by Wall St. Rank hold NGNE as of Q4 2018.

  • Jump Trading reported no remaining Neurogene position as of Q4 2018 after selling out during the quarter.
  • Jump Trading sold 915 Neurogene shares in Q4 2018, an estimated $54K.
  • Jump Trading first reported a position in Neurogene in Q3 2018 and held it in 1 quarter.
  • Jump Trading's Neurogene position peaked at $54K in Q3 2018.
  • 36 funds tracked by Wall St. Rank held Neurogene as of Q4 2018.

Based on Jump Trading's 13F filing for Q4 2018, filed 14 Feb 2019.